GastroPlus is a physiologically based pharmacokinetics platform guiding dosing and formulation from discovery to submission.

California-based Simulations Plus, Inc. provides ADMET modeling software and clinical trial data analysis for various industries.
Simulations Plus, Inc., based in Lancaster, California, develops advanced ADMET modeling and simulation software for the pharmaceutical, biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. The company also offers clinical trial data analysis and consulting services, particularly through its acquisition of Cognigen Corporation in 2014. Their mission is to translate complex scientific data into user-friendly software solutions that support drug discovery, clinical development research, and regulatory submissions.
Simulations Plus has established itself as a thought leader in ADMET property prediction, physiologically-based pharmacokinetics (PBPK) modeling, pharmacometrics, and quantitative systems pharmacology/toxicology. Their software and consulting services have significantly impacted clients' success in drug development and regulatory processes. The company's expertise and innovative solutions have made it a trusted partner in the scientific community, driving advancements in various industries.
Companies similar to Simulations Plus include Inductive Bio, Sensorygen, Biovia and Certara.
Simulations Plus was founded in 1996.
Simulations Plus' headquarters is located in Lancaster, CA, US.
Simulations Plus' most recent funding round was for $1.7M (USD) in March 2022.
As of Mar 29, 2022, Simulations Plus has disclosed funding of $1.7M (USD). Undisclosed round amounts are excluded.
Simulations Plus has 163 employees as of Feb 6, 2024.